What we are learning about CLL treatments and the microenvironment
Information is key: why patients need to be empowered to learn about their disease
The molecular genetics of follicular lymphoma
Can venetoclax be used to treat multiple myeloma (MM)?
A new prognostic tool for CLL: CLL-IPI